{"gene":"TLK1","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":1997,"finding":"TLK1 (PKU-beta) is a serine/threonine protein kinase that localizes to the nucleus via an N-terminal nuclear localization signal; the NLS-containing GST-fusion was shown to localize to the nucleus in transfection experiments, and PKU-beta expressed in COS-1 cells was predominantly nuclear.","method":"Biochemical cloning, GST-fusion nuclear localization assay, transient transfection in COS-1 cells","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiment with functional implication, single lab, moderate methods","pmids":["9427565"],"is_preprint":false},{"year":2003,"finding":"TLK1 phosphorylates histone H3 in vitro and in vivo; expression of a kinase-dead TLK1B dominant negative mutant reduced phosphorylated histone H3 levels, caused chromosome condensation defects, chromosome missegregation, and aneuploidy in normal diploid breast epithelial cells. siRNA-mediated TLK1 depletion caused S-phase cell cycle block.","method":"Kinase-dead dominant negative overexpression, FACS, immunofluorescence microscopy, siRNA knockdown","journal":"BMC cell biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (KD mutant + siRNA + FACS + microscopy), moderate evidence","pmids":["14583098"],"is_preprint":false},{"year":2005,"finding":"TLK1 phosphorylates the DEAD-box RNA helicase p68 (DDX5); in vitro kinase assay showed phosphorylation of the p68 C-terminal fragment by recombinant TLK1, and overexpression of TLK1 in HT1080 cells increased phosphorylation of endogenous p68. Phosphorylation of the p68 C-terminal fragment by TLK1 reduced its affinity for single-stranded RNA.","method":"In vitro kinase assay, gel shift assay, TLK1 overexpression in HT1080 cells, immunoprecipitation","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1/2 — in vitro kinase assay plus cell-based confirmation, single lab","pmids":["15950181"],"is_preprint":false},{"year":2008,"finding":"TLK1B binds Rad9 (component of the 9-1-1 complex) and phosphorylates hRad9 at S328; TLK1B overexpression hastened repair of DSBs, modulated 9-1-1 complex occupancy at DSBs, and stimulated chromatin reassembly adjacent to a DSB independently of kinase activity (kinase-dead TLK1B also stimulated chromatin assembly), suggesting a chaperone-like function. Rad9 and Asf1 compete for binding to TLK1B.","method":"Co-immunoprecipitation, in vitro kinase assay, S328A mutagenesis, HO endonuclease-induced DSB, chromatin assembly assay, chromatin immunoprecipitation","journal":"DNA repair","confidence":"High","confidence_rationale":"Tier 1 — reconstitution, mutagenesis, ChIP, and multiple functional assays in single study","pmids":["18940270"],"is_preprint":false},{"year":2008,"finding":"TLK1 (PKU-beta) depletion by RNAi caused reduced phosphorylation of myosin II regulatory light chain (MRLC) at Ser19/Thr18 and resulted in unequal chromosome segregation; expression of phosphomimetic DD-MRLC rescued chromosome segregation defects, indicating TLK1 regulates mitosis via MRLC phosphorylation.","method":"RNAi knockdown, immunoblot, immunofluorescence, rescue with DD-MRLC expression","journal":"Mutation research","confidence":"Medium","confidence_rationale":"Tier 2 — genetic rescue experiment with defined molecular readout, single lab","pmids":["18838128"],"is_preprint":false},{"year":2010,"finding":"In response to severe hypoxia, Chk1 is activated and phosphorylates TLK1, leading to its inactivation; this places TLK1 downstream of Chk1 in the DNA damage response pathway triggered by hypoxia-induced replication arrest.","method":"Cell-based assays under hypoxia, Chk1 loss-of-function, phosphorylation analysis","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 — epistatic pathway placement with phosphorylation readout, single lab","pmids":["20581459"],"is_preprint":false},{"year":2019,"finding":"TLK1B is upregulated following androgen deprivation therapy (ADT) and acts upstream of NEK1 and ATR to mediate the DNA damage response (DDR) in prostate cancer cells; the pathway ADT > TLK1 > NEK1 > ATR > Chk1 was established by showing that TLK1 inhibition with thioridazine impairs ATR and Chk1 activation and leads to apoptosis.","method":"TLK1 inhibitor (thioridazine) treatment, phosphorylation western blot, clonogenic survival assay, LNCaP xenografts, genetic NEK1-T141A mutant","journal":"International journal of cancer","confidence":"High","confidence_rationale":"Tier 2 — epistasis established with inhibitor, phospho-readouts, mutant rescue, and in vivo xenograft; replicated across multiple papers","pmids":["30737777"],"is_preprint":false},{"year":2019,"finding":"TLK1 phosphorylates NEK1 at T141 to activate it; p-Nek1-T141 is elevated in prostate cancer biopsies correlating with Gleason score, and the TLK1-Nek1 axis is a common adaptive response during androgen-insensitive progression.","method":"In vitro phosphorylation, NEK1-T141A mutant xenografts, tissue microarray with pNek1-T141 antibody, TRAMP mouse model with TLK1 inhibitor","journal":"Cancer letters","confidence":"High","confidence_rationale":"Tier 1/2 — kinase-substrate relationship confirmed in vitro and in vivo with mutagenesis; replicated across labs","pmids":["30928383"],"is_preprint":false},{"year":2020,"finding":"TLK1 activates NEK1 via T141 phosphorylation, and this TLK1/NEK1 axis contributes to VDAC1 phosphorylation and stability, thereby maintaining mitochondrial permeability and integrity; cells overexpressing NEK1-T141A showed increased apoptosis, cytochrome C leakage, and altered mitochondrial metabolism upon DNA damage.","method":"NEK1-T141A mutant overexpression, doxorubicin treatment, oxygen consumption measurement, cytochrome C fractionation, cell cycle analysis","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 — genetic mutant with multiple functional readouts; indirect inference of TLK1 contribution via NEK1, single lab","pmids":["31914854"],"is_preprint":false},{"year":2020,"finding":"In vitro kinase assays confirmed TLK1 inhibitory activity of the phenothiazine analog J54; J54 impairs the TLK1>NEK1>ATR>Chk1 DDR pathway and mediates apoptosis in prostate cancer cells and LNCaP xenografts.","method":"In vitro kinase assay, molecular docking, cell viability assays, xenograft model","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro kinase assay plus cellular and in vivo validation, single lab","pmids":["32905878"],"is_preprint":false},{"year":2021,"finding":"TLK1 interacts with and phosphorylates AKTIP at T22 and S237; TLK1-mediated AKTIP phosphorylation enhances AKT association with PDK1 and promotes AKT phosphorylation at T308 and S473, connecting TLK1 to the PI3K/AKT survival pathway in prostate cancer.","method":"Interactome analysis, Co-IP, in vitro phosphorylation, AKTIP knockdown, phospho-western blot, TLK1 inhibitor J54","journal":"Pathophysiology","confidence":"Medium","confidence_rationale":"Tier 2/3 — interactome plus co-IP and phospho-readouts, single lab","pmids":["35366279"],"is_preprint":false},{"year":2022,"finding":"TLK1 directly phosphorylates MK5 (MAPK-activated protein kinase 5) at S160, S354, and S386, resulting in MK5 activation; TLK1-mediated phosphorylation of MK5-S354 is required for prostate cancer cell motility, as MK5-S354A expression in MK5-null MEFs failed to rescue motility. This TLK1>MK5 axis drives PCa cell migration and invasion.","method":"In vitro kinase assay, phospho-specific antisera (pMK5-S354), Co-IP in HEK293 cells, MK5 knockout MEF rescue, 2D/3D motility assays, TLK1/MK5 KO and KD, TMA immunohistochemistry","journal":"Molecular oncology","confidence":"High","confidence_rationale":"Tier 1/2 — in vitro kinase assay, mutagenesis, genetic rescue, and orthogonal cell motility methods; replicated in follow-up papers","pmids":["35064619"],"is_preprint":false},{"year":2023,"finding":"TLK1 phosphorylates RAD54 at T41, T59 (N-terminal domain) and T700 (C-terminal domain); phosphorylation at T41 and T59 supports homologous recombination repair (HRR) and protects cells from DSB damage, while phosphorylation at T700 impairs HRR and reveals a new RAD54-CTD interaction with RAD51.","method":"ISce-I-GR-DsRed HRR reporter assay, TLK1 inhibition/depletion, site-directed mutagenesis, in vitro kinase assay, cytotoxicity assays, Co-IP with RAD51","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay, mutagenesis of multiple sites, functional HRR reporter, and protein interaction mapping in single rigorous study","pmids":["37439356"],"is_preprint":false},{"year":2024,"finding":"TLK1 and TLK2 are hyper-autophosphorylated at their N-termini via homo- or hetero-dimerization; this hyper-autophosphorylation masks a conserved non-canonical PIP box and suppresses recruitment of TLK1/2 to damaged chromatin. Mutation of the PIP box abolishes recruitment to DNA damage sites, establishing that TLK1 associates with PCNA through its PIP box to reach damage sites.","method":"Autophosphorylation assay, PIP-box mutagenesis, laser micro-irradiation/live-cell imaging at damage sites, dimerization analysis, biochemical fractionation","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of autophosphorylation, mutagenesis of PIP box, and live-cell damage recruitment assay in same study","pmids":["39727191"],"is_preprint":false},{"year":2024,"finding":"TLK1 (via NEK1) promotes nuclear retention and transcriptional activation of YAP through stabilizing phosphorylation at Y407; pYAP-Y407 shows stronger association with co-activators AR and TEAD1 and ChIP confirms YAP-wt but not YAP-Y407F occupancy at ARE- and TEAD1-driven gene promoters. TLK1 inhibitor J54 reverses YAP nuclear retention and dephosphorylates Y407.","method":"ChIP, nuclear/cytoplasmic fractionation, co-immunoprecipitation with AR/TEAD1, GFP-YAP-Y407F mutagenesis, TLK1 inhibitor J54 treatment, LNCaP and VCaP xenografts","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus mutagenesis and pharmacologic inhibition; indirect for TLK1 via NEK1, single lab","pmids":["39199688"],"is_preprint":false},{"year":2024,"finding":"A TLK1 variant (p.Q479E) associated with a neurodevelopmental disorder impairs kinase activity but does not strongly alter TLK1 localization or proximal protein interactions; cells expressing this variant showed elevated spontaneous DNA damage and reduced cytokine responses, indicating TLK1 kinase activity is required for genomic and immune homeostasis.","method":"Patient-derived lymphoblast cell lines, single-cell gel electrophoresis (comet assay), western blot for DNA damage markers, flow cytometry, RNA-seq, biochemical kinase activity assay","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in patient-derived cells with kinase-dead variant; single patient/lab","pmids":["38868186"],"is_preprint":false}],"current_model":"TLK1 is a nuclear serine/threonine kinase that, upon DNA damage, is inactivated downstream of Chk1 and, when active, phosphorylates multiple substrates including histone H3, Rad9 (S328), RAD54 (T41/T59/T700), NEK1 (T141), MK5 (S160/S354/S386), AKTIP (T22/S237), MRLC, and p68 RNA helicase to coordinate chromatin assembly, homologous recombination repair, cell cycle checkpoint signaling (TLK1>NEK1>ATR>Chk1), mitochondrial integrity (via NEK1>VDAC1), YAP nuclear activation, and cancer cell motility/metastasis; its recruitment to damaged chromatin is regulated by PCNA interaction through a PIP box that is negatively controlled by N-terminal hyper-autophosphorylation mediated by TLK1 dimerization."},"narrative":{"teleology":[{"year":1997,"claim":"Establishing that TLK1 is a serine/threonine kinase with intrinsic nuclear localization resolved its subcellular context and set the stage for identifying nuclear substrates.","evidence":"GST-fusion nuclear localization assay and COS-1 cell transfection","pmids":["9427565"],"confidence":"Medium","gaps":["Kinase substrates unknown","Cellular function uncharacterized","Only a single cell line tested"]},{"year":2003,"claim":"Demonstrating that TLK1 phosphorylates histone H3 and that its loss causes chromosome condensation defects, missegregation, and S-phase arrest linked TLK1 to chromatin regulation and cell cycle progression.","evidence":"Kinase-dead dominant negative, siRNA knockdown, FACS, and immunofluorescence in breast epithelial cells","pmids":["14583098"],"confidence":"High","gaps":["Whether H3 phosphorylation is direct or via an intermediary kinase was not fully resolved","Mechanism connecting TLK1 to S-phase arrest unclear"]},{"year":2005,"claim":"Identification of p68 RNA helicase (DDX5) as a TLK1 substrate, with phosphorylation reducing RNA binding, extended TLK1's reach beyond chromatin to RNA metabolism.","evidence":"In vitro kinase assay with recombinant TLK1, gel shift assay, TLK1 overexpression in HT1080 cells","pmids":["15950181"],"confidence":"Medium","gaps":["Phosphorylation site on p68 not mapped","In vivo functional consequence of reduced RNA binding unknown"]},{"year":2008,"claim":"Two parallel discoveries established TLK1 as a DNA damage repair factor: it phosphorylates Rad9-S328 to modulate 9-1-1 complex occupancy at DSBs and facilitates chromatin reassembly even independently of kinase activity, while also regulating mitotic chromosome segregation through MRLC phosphorylation.","evidence":"HO endonuclease DSB system with ChIP and chromatin assembly assays (Rad9); RNAi with phosphomimetic DD-MRLC rescue (MRLC)","pmids":["18940270","18838128"],"confidence":"High","gaps":["Kinase-independent chromatin assembly mechanism unresolved","Whether Rad9 and MRLC phosphorylation are coordinated during the cell cycle unknown","Asf1 vs Rad9 competition for TLK1 binding not structurally explained"]},{"year":2010,"claim":"Placing TLK1 downstream of Chk1 as a target inactivated upon DNA damage/hypoxia established TLK1 as a damage-sensitive kinase whose activity is switched off during replication stress.","evidence":"Cell-based assays under hypoxia with Chk1 loss-of-function and phosphorylation analysis","pmids":["20581459"],"confidence":"Medium","gaps":["Precise Chk1 phosphorylation site(s) on TLK1 not fully mapped","Kinetics of TLK1 reactivation after damage resolution unknown"]},{"year":2019,"claim":"Discovery that TLK1 phosphorylates NEK1 at T141 and that this feeds into the ATR–Chk1 DDR pathway created a coherent signaling axis (TLK1→NEK1→ATR→Chk1) relevant to therapy resistance in prostate cancer.","evidence":"In vitro phosphorylation, NEK1-T141A mutant xenografts, tissue microarray, thioridazine TLK1 inhibitor, TRAMP mouse model","pmids":["30737777","30928383"],"confidence":"High","gaps":["Whether TLK1 directly phosphorylates ATR or acts solely through NEK1 not resolved","Selectivity of thioridazine as a TLK1 probe limited"]},{"year":2020,"claim":"Connecting TLK1→NEK1 to VDAC1 phosphorylation and mitochondrial integrity broadened TLK1's role beyond the nucleus to include apoptosis resistance at the mitochondrial level.","evidence":"NEK1-T141A mutant overexpression, doxorubicin, oxygen consumption measurement, cytochrome C fractionation","pmids":["31914854"],"confidence":"Medium","gaps":["TLK1's contribution inferred indirectly through NEK1-T141A; direct TLK1 perturbation not shown for mitochondrial phenotypes","VDAC1 phosphorylation site by NEK1 not mapped"]},{"year":2021,"claim":"Identifying AKTIP as a TLK1 substrate (T22/S237) that enhances AKT-PDK1 association linked TLK1 to the PI3K/AKT survival pathway, providing a mechanistic explanation for TLK1's role in cancer cell survival beyond DDR.","evidence":"Co-IP, in vitro phosphorylation, AKTIP knockdown, phospho-western blot, TLK1 inhibitor J54","pmids":["35366279"],"confidence":"Medium","gaps":["AKTIP phosphorylation sites confirmed only in vitro; in vivo phospho-site verification lacking","Relative contribution of TLK1-AKTIP vs TLK1-NEK1 axes to cell survival not dissected"]},{"year":2022,"claim":"Demonstration that TLK1 directly activates MK5 via S354 phosphorylation to drive cancer cell motility established a kinase cascade (TLK1→MK5) governing migration and invasion independent of the DDR axis.","evidence":"In vitro kinase assay, MK5-S354A mutagenesis, MK5-null MEF rescue, 2D/3D motility assays","pmids":["35064619"],"confidence":"High","gaps":["Downstream effectors of MK5 mediating cytoskeletal remodeling not identified","Whether TLK1→MK5 operates in non-cancer contexts unknown"]},{"year":2023,"claim":"Mapping three TLK1 phosphorylation sites on RAD54 (T41, T59, T700) with opposing effects on homologous recombination repair revealed how TLK1 fine-tunes HR pathway output.","evidence":"ISce-I HR reporter, in vitro kinase assay, site-directed mutagenesis, Co-IP with RAD51","pmids":["37439356"],"confidence":"High","gaps":["Structural basis of opposing effects of N-terminal vs C-terminal RAD54 phosphorylation unknown","Temporal regulation of differential phosphorylation during HR not established"]},{"year":2024,"claim":"Three advances in 2024 resolved how TLK1 reaches damage sites (via a PIP box masked by dimerization-dependent autophosphorylation), linked the TLK1→NEK1 axis to YAP nuclear retention and transcriptional activation, and associated a kinase-impaired TLK1 variant with a neurodevelopmental disorder.","evidence":"PIP-box mutagenesis with laser micro-irradiation and live-cell imaging (recruitment); ChIP and YAP-Y407F mutagenesis (YAP); patient-derived lymphoblasts with comet assay and RNA-seq (disease variant)","pmids":["39727191","39199688","38868186"],"confidence":"High","gaps":["Structural basis of PIP-box masking by autophosphorylation not determined at atomic resolution","NEK1-mediated Y407 phosphorylation on YAP is indirect from TLK1—direct kinase for Y407 not identified","Single patient with Q479E variant; replication in additional families needed"]},{"year":null,"claim":"Key unresolved questions include the structural mechanism of TLK1 dimerization-dependent autophosphorylation and PIP-box regulation, the identity and regulation of TLK1 activating kinases, whether the multiple TLK1 substrate axes (NEK1, RAD54, MK5, AKTIP, H3, Rad9) are coordinated in a unified signaling logic, and the full spectrum of TLK1 loss-of-function phenotypes in human development.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of TLK1 or TLK1 dimer","Upstream activating kinase for TLK1 not identified","Relative contribution of TLK1 vs TLK2 to each substrate axis not systematically dissected"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,3,4,7,11,12]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1,13]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[3,6,12,13]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[1,3]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[1,4]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[10,14]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[8]}],"complexes":[],"partners":["NEK1","RAD9A","RAD54L","PRKAB5","AKTIP","PCNA","DDX5","TLK2"],"other_free_text":[]},"mechanistic_narrative":"TLK1 is a nuclear serine/threonine kinase that coordinates chromatin assembly, DNA damage repair, cell cycle checkpoint signaling, and mitotic fidelity through phosphorylation of a diverse substrate repertoire. It phosphorylates histone H3 to regulate chromosome condensation and segregation [PMID:14583098], Rad9 (S328) and RAD54 (T41/T59/T700) to modulate the 9-1-1 checkpoint complex and homologous recombination repair [PMID:18940270, PMID:37439356], NEK1 (T141) to activate the ATR–Chk1 DNA damage response cascade and maintain mitochondrial integrity via VDAC1 [PMID:30737777, PMID:31914854], and MK5 (S354) to drive cancer cell motility [PMID:35064619]. TLK1 is itself inactivated by Chk1-mediated phosphorylation following DNA damage or replication stress [PMID:20581459], and its recruitment to damaged chromatin requires a PCNA-interacting PIP box whose accessibility is negatively regulated by dimerization-dependent N-terminal hyper-autophosphorylation [PMID:39727191]. A TLK1 kinase-impairing variant (p.Q479E) is associated with a neurodevelopmental disorder characterized by elevated spontaneous DNA damage and altered cytokine responses [PMID:38868186]."},"prefetch_data":{"uniprot":{"accession":"Q9UKI8","full_name":"Serine/threonine-protein kinase tousled-like 1","aliases":["PKU-beta","Tousled-like kinase 1"],"length_aa":766,"mass_kda":86.7,"function":"Rapidly and transiently inhibited by phosphorylation following the generation of DNA double-stranded breaks during S-phase. This is cell cycle checkpoint and ATM-pathway dependent and appears to regulate processes involved in chromatin assembly. Isoform 3 phosphorylates and enhances the stability of the t-SNARE SNAP23, augmenting its assembly with syntaxin. Isoform 3 protects the cells from the ionizing radiation by facilitating the repair of DSBs. In vitro, phosphorylates histone H3 at 'Ser-10'","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UKI8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TLK1","classification":"Not Classified","n_dependent_lines":16,"n_total_lines":1208,"dependency_fraction":0.013245033112582781},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"TLK2","stoichiometry":10.0},{"gene":"DYNLL1","stoichiometry":0.2},{"gene":"DYNLL2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/TLK1","total_profiled":1310},"omim":[{"mim_id":"609190","title":"ANTI-SILENCING FUNCTION 1B HISTONE CHAPERONE; ASF1B","url":"https://www.omim.org/entry/609190"},{"mim_id":"609189","title":"ANTI-SILENCING FUNCTION 1A HISTONE CHAPERONE; ASF1A","url":"https://www.omim.org/entry/609189"},{"mim_id":"608439","title":"TOUSLED-LIKE KINASE 2; TLK2","url":"https://www.omim.org/entry/608439"},{"mim_id":"608438","title":"TOUSLED-LIKE KINASE 1; TLK1","url":"https://www.omim.org/entry/608438"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TLK1"},"hgnc":{"alias_symbol":["KIAA0137","PKU-BETA"],"prev_symbol":[]},"alphafold":{"accession":"Q9UKI8","domains":[{"cath_id":"3.30.200.20","chopping":"450-538","consensus_level":"high","plddt":91.4438,"start":450,"end":538},{"cath_id":"1.10.510.10","chopping":"545-733","consensus_level":"high","plddt":93.9388,"start":545,"end":733},{"cath_id":"1.10.287","chopping":"297-350_391-441","consensus_level":"medium","plddt":92.3908,"start":297,"end":441}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UKI8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UKI8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UKI8-F1-predicted_aligned_error_v6.png","plddt_mean":72.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TLK1","jax_strain_url":"https://www.jax.org/strain/search?query=TLK1"},"sequence":{"accession":"Q9UKI8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UKI8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UKI8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UKI8"}},"corpus_meta":[{"pmid":"31311824","id":"PMC_31311824","title":"Circular RNA TLK1 Aggravates Neuronal Injury and Neurological Deficits after Ischemic Stroke via miR-335-3p/TIPARP.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31311824","citation_count":177,"is_preprint":false},{"pmid":"18940270","id":"PMC_18940270","title":"Tousled homolog, TLK1, binds and phosphorylates Rad9; TLK1 acts as a molecular chaperone in DNA repair.","date":"2008","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/18940270","citation_count":63,"is_preprint":false},{"pmid":"32445866","id":"PMC_32445866","title":"The circular RNA TLK1 exacerbates myocardial ischemia/reperfusion injury via targeting miR-214/RIPK1 through TNF signaling pathway.","date":"2020","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32445866","citation_count":57,"is_preprint":false},{"pmid":"14614817","id":"PMC_14614817","title":"The C. elegans Tousled-like kinase (TLK-1) has an essential role in transcription.","date":"2003","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/14614817","citation_count":56,"is_preprint":false},{"pmid":"34250012","id":"PMC_34250012","title":"Circular RNA TLK1 Promotes Sepsis-Associated Acute Kidney Injury by Regulating Inflammation and Oxidative Stress Through miR-106a-5p/HMGB1 Axis.","date":"2021","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/34250012","citation_count":51,"is_preprint":false},{"pmid":"14583098","id":"PMC_14583098","title":"A dominant negative mutant of TLK1 causes chromosome missegregation and aneuploidy in normal breast epithelial cells.","date":"2003","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/14583098","citation_count":42,"is_preprint":false},{"pmid":"30737777","id":"PMC_30737777","title":"Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors.","date":"2019","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30737777","citation_count":40,"is_preprint":false},{"pmid":"30928383","id":"PMC_30928383","title":"The TLK1-Nek1 axis promotes prostate cancer progression.","date":"2019","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/30928383","citation_count":36,"is_preprint":false},{"pmid":"31914854","id":"PMC_31914854","title":"The TLK1/Nek1 axis contributes to mitochondrial integrity and apoptosis prevention via phosphorylation of VDAC1.","date":"2020","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/31914854","citation_count":35,"is_preprint":false},{"pmid":"32905878","id":"PMC_32905878","title":"Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy.","date":"2020","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/32905878","citation_count":30,"is_preprint":false},{"pmid":"37439356","id":"PMC_37439356","title":"TLK1-mediated RAD54 phosphorylation spatio-temporally regulates Homologous Recombination Repair.","date":"2023","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/37439356","citation_count":23,"is_preprint":false},{"pmid":"20581459","id":"PMC_20581459","title":"Exposure to acute hypoxia induces a transient DNA damage response which includes Chk1 and TLK1.","date":"2010","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/20581459","citation_count":20,"is_preprint":false},{"pmid":"18838128","id":"PMC_18838128","title":"PKU-beta/TLK1 regulates myosin II activities, and is required for accurate equaled chromosome segregation.","date":"2008","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/18838128","citation_count":14,"is_preprint":false},{"pmid":"35064619","id":"PMC_35064619","title":"TLK1-mediated MK5-S354 phosphorylation drives prostate cancer cell motility and may signify distinct pathologies.","date":"2022","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35064619","citation_count":11,"is_preprint":false},{"pmid":"35359342","id":"PMC_35359342","title":"Circular RNA TLK1 Exerts Oncogenic Functions in Hepatocellular Carcinoma by Acting as a ceRNA of miR-138-5p.","date":"2022","source":"Journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35359342","citation_count":11,"is_preprint":false},{"pmid":"9427565","id":"PMC_9427565","title":"cDNA cloning and chromosomal mapping of genes encoding novel protein kinases termed PKU-alpha and PKU-beta, which have nuclear localization signal.","date":"1997","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9427565","citation_count":11,"is_preprint":false},{"pmid":"34181173","id":"PMC_34181173","title":"Inhibiting of circ-TLK1 inhibits the progression of glioma through down-regulating PANX1 via targeting miR-17-5p.","date":"2021","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/34181173","citation_count":10,"is_preprint":false},{"pmid":"36497211","id":"PMC_36497211","title":"The TLK1-MK5 Axis Regulates Motility, Invasion, and Metastasis of Prostate Cancer Cells.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36497211","citation_count":9,"is_preprint":false},{"pmid":"35366279","id":"PMC_35366279","title":"Interaction of TLK1 and AKTIP as a Potential Regulator of AKT Activation in Castration-Resistant Prostate Cancer Progression.","date":"2021","source":"Pathophysiology : the official journal of the International Society for Pathophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/35366279","citation_count":9,"is_preprint":false},{"pmid":"15950181","id":"PMC_15950181","title":"Identification of the human DEAD-box protein p68 as a substrate of Tlk1.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15950181","citation_count":7,"is_preprint":false},{"pmid":"38001987","id":"PMC_38001987","title":"Exploiting TLK1 and Cisplatin Synergy for Synthetic Lethality in Androgen-Insensitive Prostate Cancer.","date":"2023","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/38001987","citation_count":4,"is_preprint":false},{"pmid":"36947060","id":"PMC_36947060","title":"The interaction between ASF1B and TLK1 promotes the malignant progression of low-grade glioma.","date":"2023","source":"Annals of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36947060","citation_count":4,"is_preprint":false},{"pmid":"38868186","id":"PMC_38868186","title":"De novo TLK1 and MDM1 mutations in a patient with a neurodevelopmental disorder and immunodeficiency.","date":"2024","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/38868186","citation_count":3,"is_preprint":false},{"pmid":"39029318","id":"PMC_39029318","title":"A novel approach to investigate the combinatorial effects of TLK1 (Tousled-Like Kinase1) inhibitors with Temozolomide for glioblastoma therapy.","date":"2024","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39029318","citation_count":3,"is_preprint":false},{"pmid":"39199688","id":"PMC_39199688","title":"TLK1>Nek1 Axis Promotes Nuclear Retention and Activation of YAP with Implications for Castration-Resistant Prostate Cancer.","date":"2024","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/39199688","citation_count":3,"is_preprint":false},{"pmid":"20705056","id":"PMC_20705056","title":"Caenorhabditis elegans TLK-1 controls cytokinesis by localizing AIR-2/Aurora B to midzone microtubules.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20705056","citation_count":3,"is_preprint":false},{"pmid":"37662408","id":"PMC_37662408","title":"Identification of a de novo mutation in TLK1 associated with a neurodevelopmental disorder and immunodeficiency.","date":"2023","source":"medRxiv : the preprint server for health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37662408","citation_count":2,"is_preprint":false},{"pmid":"35766911","id":"PMC_35766911","title":"Circ_TLK1 knockdown alleviates oxygen-glucose deprivation/reoxygenation-induced PC12 cell injury by regulating microRNA-136-5p/follistatin like-1 axis.","date":"2022","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35766911","citation_count":2,"is_preprint":false},{"pmid":"40058222","id":"PMC_40058222","title":"Characterization of new non-ATP dependent inhibitors of TLK1 as potential molecules for treating prostate cancer.","date":"2025","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40058222","citation_count":2,"is_preprint":false},{"pmid":"38712247","id":"PMC_38712247","title":"Autophosphorylation of the Tousled-like kinases TLK1 and TLK2 regulates recruitment to damaged chromatin via PCNA interaction.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38712247","citation_count":1,"is_preprint":false},{"pmid":"38925844","id":"PMC_38925844","title":"TLK1 Inhibition Enhances the Anticancer Effect of Deep UV Irradiation Through CHK1 Activation.","date":"2024","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/38925844","citation_count":1,"is_preprint":false},{"pmid":"40287404","id":"PMC_40287404","title":"TLK1 as a therapeutic target in TMZ resistant glioblastoma using small molecule inhibitor.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40287404","citation_count":1,"is_preprint":false},{"pmid":"39727191","id":"PMC_39727191","title":"Autophosphorylation of the Tousled-like kinases TLK1 and TLK2 regulates recruitment to damaged chromatin via PCNA interaction.","date":"2025","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/39727191","citation_count":0,"is_preprint":false},{"pmid":"40227796","id":"PMC_40227796","title":"Targeting the TLK1-MK5 Axis Suppresses Prostate Cancer Metastasis.","date":"2025","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/40227796","citation_count":0,"is_preprint":false},{"pmid":"40369698","id":"PMC_40369698","title":"Mechanistic insights into Circ-MBOAT2-mediated regulation of TLK1 through miR-664b-3p in non-small cell lung cancer.","date":"2025","source":"Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/40369698","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.18.25329418","title":"Imputation of fluid intelligence scores reduces ascertainment bias and increases power for analyses of common and rare variants","date":"2025-06-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.18.25329418","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20270,"output_tokens":4194,"usd":0.06186},"stage2":{"model":"claude-opus-4-6","input_tokens":7609,"output_tokens":3111,"usd":0.17373},"total_usd":0.23559,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"TLK1 (PKU-beta) is a serine/threonine protein kinase that localizes to the nucleus via an N-terminal nuclear localization signal; the NLS-containing GST-fusion was shown to localize to the nucleus in transfection experiments, and PKU-beta expressed in COS-1 cells was predominantly nuclear.\",\n      \"method\": \"Biochemical cloning, GST-fusion nuclear localization assay, transient transfection in COS-1 cells\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional implication, single lab, moderate methods\",\n      \"pmids\": [\"9427565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TLK1 phosphorylates histone H3 in vitro and in vivo; expression of a kinase-dead TLK1B dominant negative mutant reduced phosphorylated histone H3 levels, caused chromosome condensation defects, chromosome missegregation, and aneuploidy in normal diploid breast epithelial cells. siRNA-mediated TLK1 depletion caused S-phase cell cycle block.\",\n      \"method\": \"Kinase-dead dominant negative overexpression, FACS, immunofluorescence microscopy, siRNA knockdown\",\n      \"journal\": \"BMC cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KD mutant + siRNA + FACS + microscopy), moderate evidence\",\n      \"pmids\": [\"14583098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TLK1 phosphorylates the DEAD-box RNA helicase p68 (DDX5); in vitro kinase assay showed phosphorylation of the p68 C-terminal fragment by recombinant TLK1, and overexpression of TLK1 in HT1080 cells increased phosphorylation of endogenous p68. Phosphorylation of the p68 C-terminal fragment by TLK1 reduced its affinity for single-stranded RNA.\",\n      \"method\": \"In vitro kinase assay, gel shift assay, TLK1 overexpression in HT1080 cells, immunoprecipitation\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1/2 — in vitro kinase assay plus cell-based confirmation, single lab\",\n      \"pmids\": [\"15950181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TLK1B binds Rad9 (component of the 9-1-1 complex) and phosphorylates hRad9 at S328; TLK1B overexpression hastened repair of DSBs, modulated 9-1-1 complex occupancy at DSBs, and stimulated chromatin reassembly adjacent to a DSB independently of kinase activity (kinase-dead TLK1B also stimulated chromatin assembly), suggesting a chaperone-like function. Rad9 and Asf1 compete for binding to TLK1B.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, S328A mutagenesis, HO endonuclease-induced DSB, chromatin assembly assay, chromatin immunoprecipitation\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution, mutagenesis, ChIP, and multiple functional assays in single study\",\n      \"pmids\": [\"18940270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TLK1 (PKU-beta) depletion by RNAi caused reduced phosphorylation of myosin II regulatory light chain (MRLC) at Ser19/Thr18 and resulted in unequal chromosome segregation; expression of phosphomimetic DD-MRLC rescued chromosome segregation defects, indicating TLK1 regulates mitosis via MRLC phosphorylation.\",\n      \"method\": \"RNAi knockdown, immunoblot, immunofluorescence, rescue with DD-MRLC expression\",\n      \"journal\": \"Mutation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic rescue experiment with defined molecular readout, single lab\",\n      \"pmids\": [\"18838128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In response to severe hypoxia, Chk1 is activated and phosphorylates TLK1, leading to its inactivation; this places TLK1 downstream of Chk1 in the DNA damage response pathway triggered by hypoxia-induced replication arrest.\",\n      \"method\": \"Cell-based assays under hypoxia, Chk1 loss-of-function, phosphorylation analysis\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistatic pathway placement with phosphorylation readout, single lab\",\n      \"pmids\": [\"20581459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TLK1B is upregulated following androgen deprivation therapy (ADT) and acts upstream of NEK1 and ATR to mediate the DNA damage response (DDR) in prostate cancer cells; the pathway ADT > TLK1 > NEK1 > ATR > Chk1 was established by showing that TLK1 inhibition with thioridazine impairs ATR and Chk1 activation and leads to apoptosis.\",\n      \"method\": \"TLK1 inhibitor (thioridazine) treatment, phosphorylation western blot, clonogenic survival assay, LNCaP xenografts, genetic NEK1-T141A mutant\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis established with inhibitor, phospho-readouts, mutant rescue, and in vivo xenograft; replicated across multiple papers\",\n      \"pmids\": [\"30737777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TLK1 phosphorylates NEK1 at T141 to activate it; p-Nek1-T141 is elevated in prostate cancer biopsies correlating with Gleason score, and the TLK1-Nek1 axis is a common adaptive response during androgen-insensitive progression.\",\n      \"method\": \"In vitro phosphorylation, NEK1-T141A mutant xenografts, tissue microarray with pNek1-T141 antibody, TRAMP mouse model with TLK1 inhibitor\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — kinase-substrate relationship confirmed in vitro and in vivo with mutagenesis; replicated across labs\",\n      \"pmids\": [\"30928383\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TLK1 activates NEK1 via T141 phosphorylation, and this TLK1/NEK1 axis contributes to VDAC1 phosphorylation and stability, thereby maintaining mitochondrial permeability and integrity; cells overexpressing NEK1-T141A showed increased apoptosis, cytochrome C leakage, and altered mitochondrial metabolism upon DNA damage.\",\n      \"method\": \"NEK1-T141A mutant overexpression, doxorubicin treatment, oxygen consumption measurement, cytochrome C fractionation, cell cycle analysis\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic mutant with multiple functional readouts; indirect inference of TLK1 contribution via NEK1, single lab\",\n      \"pmids\": [\"31914854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In vitro kinase assays confirmed TLK1 inhibitory activity of the phenothiazine analog J54; J54 impairs the TLK1>NEK1>ATR>Chk1 DDR pathway and mediates apoptosis in prostate cancer cells and LNCaP xenografts.\",\n      \"method\": \"In vitro kinase assay, molecular docking, cell viability assays, xenograft model\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay plus cellular and in vivo validation, single lab\",\n      \"pmids\": [\"32905878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TLK1 interacts with and phosphorylates AKTIP at T22 and S237; TLK1-mediated AKTIP phosphorylation enhances AKT association with PDK1 and promotes AKT phosphorylation at T308 and S473, connecting TLK1 to the PI3K/AKT survival pathway in prostate cancer.\",\n      \"method\": \"Interactome analysis, Co-IP, in vitro phosphorylation, AKTIP knockdown, phospho-western blot, TLK1 inhibitor J54\",\n      \"journal\": \"Pathophysiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — interactome plus co-IP and phospho-readouts, single lab\",\n      \"pmids\": [\"35366279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TLK1 directly phosphorylates MK5 (MAPK-activated protein kinase 5) at S160, S354, and S386, resulting in MK5 activation; TLK1-mediated phosphorylation of MK5-S354 is required for prostate cancer cell motility, as MK5-S354A expression in MK5-null MEFs failed to rescue motility. This TLK1>MK5 axis drives PCa cell migration and invasion.\",\n      \"method\": \"In vitro kinase assay, phospho-specific antisera (pMK5-S354), Co-IP in HEK293 cells, MK5 knockout MEF rescue, 2D/3D motility assays, TLK1/MK5 KO and KD, TMA immunohistochemistry\",\n      \"journal\": \"Molecular oncology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — in vitro kinase assay, mutagenesis, genetic rescue, and orthogonal cell motility methods; replicated in follow-up papers\",\n      \"pmids\": [\"35064619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TLK1 phosphorylates RAD54 at T41, T59 (N-terminal domain) and T700 (C-terminal domain); phosphorylation at T41 and T59 supports homologous recombination repair (HRR) and protects cells from DSB damage, while phosphorylation at T700 impairs HRR and reveals a new RAD54-CTD interaction with RAD51.\",\n      \"method\": \"ISce-I-GR-DsRed HRR reporter assay, TLK1 inhibition/depletion, site-directed mutagenesis, in vitro kinase assay, cytotoxicity assays, Co-IP with RAD51\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay, mutagenesis of multiple sites, functional HRR reporter, and protein interaction mapping in single rigorous study\",\n      \"pmids\": [\"37439356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TLK1 and TLK2 are hyper-autophosphorylated at their N-termini via homo- or hetero-dimerization; this hyper-autophosphorylation masks a conserved non-canonical PIP box and suppresses recruitment of TLK1/2 to damaged chromatin. Mutation of the PIP box abolishes recruitment to DNA damage sites, establishing that TLK1 associates with PCNA through its PIP box to reach damage sites.\",\n      \"method\": \"Autophosphorylation assay, PIP-box mutagenesis, laser micro-irradiation/live-cell imaging at damage sites, dimerization analysis, biochemical fractionation\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of autophosphorylation, mutagenesis of PIP box, and live-cell damage recruitment assay in same study\",\n      \"pmids\": [\"39727191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TLK1 (via NEK1) promotes nuclear retention and transcriptional activation of YAP through stabilizing phosphorylation at Y407; pYAP-Y407 shows stronger association with co-activators AR and TEAD1 and ChIP confirms YAP-wt but not YAP-Y407F occupancy at ARE- and TEAD1-driven gene promoters. TLK1 inhibitor J54 reverses YAP nuclear retention and dephosphorylates Y407.\",\n      \"method\": \"ChIP, nuclear/cytoplasmic fractionation, co-immunoprecipitation with AR/TEAD1, GFP-YAP-Y407F mutagenesis, TLK1 inhibitor J54 treatment, LNCaP and VCaP xenografts\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus mutagenesis and pharmacologic inhibition; indirect for TLK1 via NEK1, single lab\",\n      \"pmids\": [\"39199688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A TLK1 variant (p.Q479E) associated with a neurodevelopmental disorder impairs kinase activity but does not strongly alter TLK1 localization or proximal protein interactions; cells expressing this variant showed elevated spontaneous DNA damage and reduced cytokine responses, indicating TLK1 kinase activity is required for genomic and immune homeostasis.\",\n      \"method\": \"Patient-derived lymphoblast cell lines, single-cell gel electrophoresis (comet assay), western blot for DNA damage markers, flow cytometry, RNA-seq, biochemical kinase activity assay\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in patient-derived cells with kinase-dead variant; single patient/lab\",\n      \"pmids\": [\"38868186\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TLK1 is a nuclear serine/threonine kinase that, upon DNA damage, is inactivated downstream of Chk1 and, when active, phosphorylates multiple substrates including histone H3, Rad9 (S328), RAD54 (T41/T59/T700), NEK1 (T141), MK5 (S160/S354/S386), AKTIP (T22/S237), MRLC, and p68 RNA helicase to coordinate chromatin assembly, homologous recombination repair, cell cycle checkpoint signaling (TLK1>NEK1>ATR>Chk1), mitochondrial integrity (via NEK1>VDAC1), YAP nuclear activation, and cancer cell motility/metastasis; its recruitment to damaged chromatin is regulated by PCNA interaction through a PIP box that is negatively controlled by N-terminal hyper-autophosphorylation mediated by TLK1 dimerization.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TLK1 is a nuclear serine/threonine kinase that coordinates chromatin assembly, DNA damage repair, cell cycle checkpoint signaling, and mitotic fidelity through phosphorylation of a diverse substrate repertoire. It phosphorylates histone H3 to regulate chromosome condensation and segregation [PMID:14583098], Rad9 (S328) and RAD54 (T41/T59/T700) to modulate the 9-1-1 checkpoint complex and homologous recombination repair [PMID:18940270, PMID:37439356], NEK1 (T141) to activate the ATR–Chk1 DNA damage response cascade and maintain mitochondrial integrity via VDAC1 [PMID:30737777, PMID:31914854], and MK5 (S354) to drive cancer cell motility [PMID:35064619]. TLK1 is itself inactivated by Chk1-mediated phosphorylation following DNA damage or replication stress [PMID:20581459], and its recruitment to damaged chromatin requires a PCNA-interacting PIP box whose accessibility is negatively regulated by dimerization-dependent N-terminal hyper-autophosphorylation [PMID:39727191]. A TLK1 kinase-impairing variant (p.Q479E) is associated with a neurodevelopmental disorder characterized by elevated spontaneous DNA damage and altered cytokine responses [PMID:38868186].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing that TLK1 is a serine/threonine kinase with intrinsic nuclear localization resolved its subcellular context and set the stage for identifying nuclear substrates.\",\n      \"evidence\": \"GST-fusion nuclear localization assay and COS-1 cell transfection\",\n      \"pmids\": [\"9427565\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase substrates unknown\", \"Cellular function uncharacterized\", \"Only a single cell line tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrating that TLK1 phosphorylates histone H3 and that its loss causes chromosome condensation defects, missegregation, and S-phase arrest linked TLK1 to chromatin regulation and cell cycle progression.\",\n      \"evidence\": \"Kinase-dead dominant negative, siRNA knockdown, FACS, and immunofluorescence in breast epithelial cells\",\n      \"pmids\": [\"14583098\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether H3 phosphorylation is direct or via an intermediary kinase was not fully resolved\", \"Mechanism connecting TLK1 to S-phase arrest unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of p68 RNA helicase (DDX5) as a TLK1 substrate, with phosphorylation reducing RNA binding, extended TLK1's reach beyond chromatin to RNA metabolism.\",\n      \"evidence\": \"In vitro kinase assay with recombinant TLK1, gel shift assay, TLK1 overexpression in HT1080 cells\",\n      \"pmids\": [\"15950181\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Phosphorylation site on p68 not mapped\", \"In vivo functional consequence of reduced RNA binding unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Two parallel discoveries established TLK1 as a DNA damage repair factor: it phosphorylates Rad9-S328 to modulate 9-1-1 complex occupancy at DSBs and facilitates chromatin reassembly even independently of kinase activity, while also regulating mitotic chromosome segregation through MRLC phosphorylation.\",\n      \"evidence\": \"HO endonuclease DSB system with ChIP and chromatin assembly assays (Rad9); RNAi with phosphomimetic DD-MRLC rescue (MRLC)\",\n      \"pmids\": [\"18940270\", \"18838128\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase-independent chromatin assembly mechanism unresolved\", \"Whether Rad9 and MRLC phosphorylation are coordinated during the cell cycle unknown\", \"Asf1 vs Rad9 competition for TLK1 binding not structurally explained\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Placing TLK1 downstream of Chk1 as a target inactivated upon DNA damage/hypoxia established TLK1 as a damage-sensitive kinase whose activity is switched off during replication stress.\",\n      \"evidence\": \"Cell-based assays under hypoxia with Chk1 loss-of-function and phosphorylation analysis\",\n      \"pmids\": [\"20581459\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Precise Chk1 phosphorylation site(s) on TLK1 not fully mapped\", \"Kinetics of TLK1 reactivation after damage resolution unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery that TLK1 phosphorylates NEK1 at T141 and that this feeds into the ATR–Chk1 DDR pathway created a coherent signaling axis (TLK1→NEK1→ATR→Chk1) relevant to therapy resistance in prostate cancer.\",\n      \"evidence\": \"In vitro phosphorylation, NEK1-T141A mutant xenografts, tissue microarray, thioridazine TLK1 inhibitor, TRAMP mouse model\",\n      \"pmids\": [\"30737777\", \"30928383\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TLK1 directly phosphorylates ATR or acts solely through NEK1 not resolved\", \"Selectivity of thioridazine as a TLK1 probe limited\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Connecting TLK1→NEK1 to VDAC1 phosphorylation and mitochondrial integrity broadened TLK1's role beyond the nucleus to include apoptosis resistance at the mitochondrial level.\",\n      \"evidence\": \"NEK1-T141A mutant overexpression, doxorubicin, oxygen consumption measurement, cytochrome C fractionation\",\n      \"pmids\": [\"31914854\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TLK1's contribution inferred indirectly through NEK1-T141A; direct TLK1 perturbation not shown for mitochondrial phenotypes\", \"VDAC1 phosphorylation site by NEK1 not mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying AKTIP as a TLK1 substrate (T22/S237) that enhances AKT-PDK1 association linked TLK1 to the PI3K/AKT survival pathway, providing a mechanistic explanation for TLK1's role in cancer cell survival beyond DDR.\",\n      \"evidence\": \"Co-IP, in vitro phosphorylation, AKTIP knockdown, phospho-western blot, TLK1 inhibitor J54\",\n      \"pmids\": [\"35366279\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"AKTIP phosphorylation sites confirmed only in vitro; in vivo phospho-site verification lacking\", \"Relative contribution of TLK1-AKTIP vs TLK1-NEK1 axes to cell survival not dissected\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstration that TLK1 directly activates MK5 via S354 phosphorylation to drive cancer cell motility established a kinase cascade (TLK1→MK5) governing migration and invasion independent of the DDR axis.\",\n      \"evidence\": \"In vitro kinase assay, MK5-S354A mutagenesis, MK5-null MEF rescue, 2D/3D motility assays\",\n      \"pmids\": [\"35064619\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors of MK5 mediating cytoskeletal remodeling not identified\", \"Whether TLK1→MK5 operates in non-cancer contexts unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Mapping three TLK1 phosphorylation sites on RAD54 (T41, T59, T700) with opposing effects on homologous recombination repair revealed how TLK1 fine-tunes HR pathway output.\",\n      \"evidence\": \"ISce-I HR reporter, in vitro kinase assay, site-directed mutagenesis, Co-IP with RAD51\",\n      \"pmids\": [\"37439356\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of opposing effects of N-terminal vs C-terminal RAD54 phosphorylation unknown\", \"Temporal regulation of differential phosphorylation during HR not established\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Three advances in 2024 resolved how TLK1 reaches damage sites (via a PIP box masked by dimerization-dependent autophosphorylation), linked the TLK1→NEK1 axis to YAP nuclear retention and transcriptional activation, and associated a kinase-impaired TLK1 variant with a neurodevelopmental disorder.\",\n      \"evidence\": \"PIP-box mutagenesis with laser micro-irradiation and live-cell imaging (recruitment); ChIP and YAP-Y407F mutagenesis (YAP); patient-derived lymphoblasts with comet assay and RNA-seq (disease variant)\",\n      \"pmids\": [\"39727191\", \"39199688\", \"38868186\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of PIP-box masking by autophosphorylation not determined at atomic resolution\", \"NEK1-mediated Y407 phosphorylation on YAP is indirect from TLK1—direct kinase for Y407 not identified\", \"Single patient with Q479E variant; replication in additional families needed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural mechanism of TLK1 dimerization-dependent autophosphorylation and PIP-box regulation, the identity and regulation of TLK1 activating kinases, whether the multiple TLK1 substrate axes (NEK1, RAD54, MK5, AKTIP, H3, Rad9) are coordinated in a unified signaling logic, and the full spectrum of TLK1 loss-of-function phenotypes in human development.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of TLK1 or TLK1 dimer\", \"Upstream activating kinase for TLK1 not identified\", \"Relative contribution of TLK1 vs TLK2 to each substrate axis not systematically dissected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 3, 4, 7, 11, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [3, 6, 12, 13]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [10, 14]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"NEK1\",\n      \"RAD9A\",\n      \"RAD54L\",\n      \"PRKAB5\",\n      \"AKTIP\",\n      \"PCNA\",\n      \"DDX5\",\n      \"TLK2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}